Mumbai, Nov 11 (PTI) Pharma firm Cipla Ltd today said it is looking to export Antiflu, the drug used in the treatment of influenza AH1N1 (swine flu) virus, to US markets.

"There is a shortage of this drug in the US. We have made an offer and willing to make this drug available in the US markets," Cipla Chairman and Managing Director Y K Hamied told reporters here.

Other countries also can approach us for the supply of Antiflu, he said while announcing the launch of the drug.

"We have launched Oseltamivir brand, called Antiflu, which is the only anti-flu medicine from India to be prequalified by the World Health Organisation (WHO)," Hamied said.

The company has the capacity to produce up to two million doses a month to meet the growing requirement of this medicine.